Skip to content

Study Eligibility

PASS is for men who have chosen to use active surveillance to manage their prostate cancer.

Eligible participants must have clinically localized prostate cancer and have not received surgery, radiation, or other medical treatment for prostate cancer.

For full inclusion and exclusion criteria and to enroll in the study, please review the study details and contacts listed on the Clinical Trials website.